Business Description
ImmuPharma PLC
NAICS : 325412
ISIN : GB0033711010
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.53 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31.2 | |||||
3-Year EPS without NRI Growth Rate | 39.2 | |||||
3-Year FCF Growth Rate | 34.1 | |||||
3-Year Book Growth Rate | -36.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.82 | |||||
9-Day RSI | 53.69 | |||||
14-Day RSI | 52.77 | |||||
6-1 Month Momentum % | 40.35 | |||||
12-1 Month Momentum % | -16.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.14 | |||||
Days Sales Outstanding | 1713.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3795.71 | |||||
Net Margin % | -4272.86 | |||||
FCF Margin % | -1965.71 | |||||
ROE % | -142.95 | |||||
ROA % | -88.51 | |||||
ROIC % | -116.69 | |||||
ROC (Joel Greenblatt) % | -871.02 | |||||
ROCE % | -188.16 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.33 | |||||
EV-to-EBIT | -2.24 | |||||
EV-to-EBITDA | -2.29 | |||||
EV-to-Revenue | 125.79 | |||||
EV-to-FCF | -6.4 | |||||
Earnings Yield (Greenblatt) % | -44.64 | |||||
FCF Yield % | -15.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ImmuPharma PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 0.07 | ||
EPS (TTM) (£) | -0.01 | ||
Beta | 3.76 | ||
Volatility % | 58.15 | ||
14-Day RSI | 52.77 | ||
14-Day ATR (£) | 0.002765 | ||
20-Day SMA (£) | 0.021838 | ||
12-1 Month Momentum % | -16.81 | ||
52-Week Range (£) | 0.00822 - 0.038 | ||
Shares Outstanding (Mil) | 416.44 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ImmuPharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ImmuPharma PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
ImmuPharma PLC Frequently Asked Questions
What is ImmuPharma PLC(LSE:IMM)'s stock price today?
When is next earnings date of ImmuPharma PLC(LSE:IMM)?
Does ImmuPharma PLC(LSE:IMM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |